Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Kortüm

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Der Internist|December 12, 2018
[Diagnostic and therapeutic considerations on recurrence of multiple myeloma : A current overview]K M Kortüm, H Einsele
Der Internist|July 18, 2013
[Multiple myeloma]K M Kortüm, M Engelhardt, L Rasche, et al.
Blood Reviews|April 7, 2015
Cereblon binding molecules in multiple myelomaK M Kortüm, Y X Zhu, C X Shi, et al.
Blood Cancer Journal|January 16, 2016
Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?A Rosenthal, J Luthi, M Belohlavek, et al.
Leukemia|July 30, 2016
Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcomeS Barrio, T D Shanafelt, J Ojha, et al.
Annals of Hematology|December 20, 2023
Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myelomaC Riedhammer, J Düll, C Kestler, et al.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
Journal of Translational Medicine|April 23, 2020
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytesM J Steinhardt, E Wiercinska, M Pham, et al.
Leukemia|February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5DC Riedhammer, M Truger, H Lee, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Der Internist|December 12, 2018
[Diagnostic and therapeutic considerations on recurrence of multiple myeloma : A current overview]K M Kortüm, H Einsele
Der Internist|July 18, 2013
[Multiple myeloma]K M Kortüm, M Engelhardt, L Rasche, et al.
Blood Reviews|April 7, 2015
Cereblon binding molecules in multiple myelomaK M Kortüm, Y X Zhu, C X Shi, et al.
Blood Cancer Journal|January 16, 2016
Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?A Rosenthal, J Luthi, M Belohlavek, et al.
Leukemia|July 30, 2016
Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcomeS Barrio, T D Shanafelt, J Ojha, et al.
Annals of Hematology|December 20, 2023
Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myelomaC Riedhammer, J Düll, C Kestler, et al.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
Journal of Translational Medicine|April 23, 2020
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytesM J Steinhardt, E Wiercinska, M Pham, et al.
Leukemia|February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5DC Riedhammer, M Truger, H Lee, et al.
Pageof 1